Results 251 to 260 of about 25,791,466 (309)
Some of the next articles are maybe not open access.

The protein C pathways

Current Opinion in Hematology, 2022
Purpose of review To provide an overview of the state-of-the-art in protein C (PC) pathway research. Recent findings The PC pathway is crucial for maintaining hemostasis to prevent venous thromboembolism.
Gemma, Leon   +2 more
openaire   +2 more sources

Activated protein C

Journal of Thrombosis and Haemostasis, 2007
Protein C is a vitamin K-dependent plasma protein zymogen whose genetic mild or severe deficiencies are linked with risk for venous thrombosis or neonatal purpura fulminans, respectively. Studies over past decades showed that activated protein C (APC) inactivates factors (F) Va and VIIIa to down-regulate thrombin generation.
J H, Griffin   +3 more
openaire   +2 more sources

Protein kinase C

Pharmacology & Therapeutics, 1991
Based on the molecular structure of the individual members of the protein kinase C family, general properties and the mode of activation of this enzyme family are discussed. Examples are presented of how the investigation of protein kinase C function in vivo has been approached at the molecular level.
S, Stabel, P J, Parker
openaire   +2 more sources

Protein Kinase C

Journal of Cellular Physiology, 1986
The combined application of protein structural techniques, immunochemistry, and molecular biology has permitted an analysis of the differential expression of the genes for the three related protein kinases, C-alpha, -beta, and gamma. The evidence now suggests that the type of protein kinase C in a cell may govern the nature and mechanisms of functional
P J, Parker, A, Ullrich
openaire   +2 more sources

Protein C Inhibitor

Seminars in Thrombosis and Hemostasis, 2011
Protein C inhibitor (PCI) is a serine protease inhibitor and was originally identified as an inhibitor of activated protein C (APC). However, PCI is not specific for APC and also inhibits several proteases involved in coagulation, fibrinolysis, cancer, wound healing, and fertility.
Meijers, Joost C. M., Herwald, Heiko
openaire   +2 more sources

Protein C

2013
Protein C (PC) is a 62-kDa vitamin K-dependent plasma zymogen which, after activation to serine protease, plays an important role in the physiologic regulation of blood coagulation. Given that PC is one of the major naturally occurring inhibitors of coagulation, acquired or hereditary deficiencies of this protein result in excessive thrombin generation.
Mirta, Hepner, Vasiliki, Karlaftis
openaire   +2 more sources

Homozygous protein C deficiency—management with protein C concentrate

European Journal of Pediatrics, 1995
Two unrelated female infants with homozygous protein C (Pr C) deficiency are reported. Both are of U.K. Pakistani origin and in each case the parents are consanguinous. A previous sibling had died in each family. Both sets of parents were shown to be carriers. The concentration of Pr C in both infants was low at birth.
V, Baliga   +5 more
openaire   +2 more sources

The C-reactive protein

The Journal of Emergency Medicine, 1999
C-reactive protein (CRP) was identified in 1930 and was subsequently considered to be an "acute phase protein," an early indicator of infectious or inflammatory conditions. Since its discovery, CRP has been studied as a screening device for inflammation, a marker for disease activity, and as a diagnostic adjunct.
B, Clyne, J S, Olshaker
openaire   +2 more sources

Protein C deficiency

Haemophilia, 2008
Summary.  Severe protein C deficiency (i.e. protein C activity <1 IU dL−1) is a rare autosomal recessive disorder that usually presents in the neonatal period with purpura fulminans (PF) and severe disseminated intravascular coagulation (DIC), often with concomitant venous thromboembolism (VTE).
N A, Goldenberg, M J, Manco-Johnson
openaire   +2 more sources

Home - About - Disclaimer - Privacy